GlassScriptPhysician profile
Kent Olsen
NPI 1003445230
$2,682.02
in general payments reported to CMS, 2019-2025
19 companies · $449 in 2025
The $449 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,432 · 2024: $801 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992 · Travel and Lodging: $641 · Education: $48.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.79 |
| Travel and Lodging | $641.35 |
| Education | $48.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,617.44 | 2023-2025 | Salvation, Viaflow, Augment Injectable |
| Integra Lifesciences Corporation | $158.46 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $149.67 | 2024 | Cerament G, Ceramentbone Void Filler |
| Organogenesis INC. | $147.73 | 2023-2024 | Affinity, Puraply |
| Axogen | $117.78 | 2023 | Avance Nerve Graft |
| Smith+Nephew, INC. | $115.69 | 2024-2025 | Collagenase Santyl, Stravix Pl, Grafix Pl |
| Medtronic, INC. | $66.58 | 2024 | Venaseal |
| Medshape, INC. | $65.40 | 2024 | Dynanail |
| Polynovo North America LLC | $39.89 | 2025 | Novosorb Btm |
| Innovation Technologies INC | $30.20 | 2023 | Irrisept |
| Solventum Corporation | $25.82 | 2025 | Activ.A.C. |
| Averitas Pharma INC. | $23.17 | 2025 | Qutenza |
| Core Surgical Group | $21.57 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $21.12 | 2025 | |
| Nevro Corp. | $18.84 | 2024 | Senza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $16.66 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $16.58 | 2024 | |
| Mimedx Group, INC. | $15.87 | 2024 | |
| Bioventus LLC | $13.55 | 2025 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Olsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.